This announcement is a separate document:
李氏大藥廠:進一步延遲寄發通函 - 建議將 Zhaoke Ophthalmology Limited 分拆及於聯交所主板獨立上市
LEE'S PHARM: Further Delay in Despatch of Circular - Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.